Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma

Virology Journal

Volumn 2, Issue , 2005, Pages

  Sainz Jr , Bruno ^a   LaMarca, Heather L ^a   Garry, Robert F ^a   Morris, Cindy A ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; GAMMA INTERFERON; IMMEDIATE EARLY PROTEIN; MESSENGER RNA;

ARTICLE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION REGULATION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMEDIATE EARLY GENE; IMMUNE RESPONSE; IMMUNOCHEMISTRY; IMMUNOFLUORESCENCE; IN VITRO STUDY; INHIBITION KINETICS; INNATE IMMUNITY; NONHUMAN; PLAQUE FORMING CELL; PREPUCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; VIRUS GENE; VIRUS INHIBITION; VIRUS REPLICATION; WESTERN BLOTTING;

ANTIVIRAL AGENTS; CELLS, CULTURED; CYTOMEGALOVIRUS; DRUG SYNERGISM; FIBROBLASTS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; INTERFERON-GAMMA; RNA, MESSENGER; VIRAL PLAQUE ASSAY; VIRUS REPLICATION;

HERPES; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 5;

EID: 18044384406     PISSN: 1743422X     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-2-14     Document Type: Article

References (58)

1. Trincado DE, Rawlinson WD: Congenital and perinatal infections with cytomegalovirus. J Paediatr Child Health 2001, 37:187-192.
2. Mocarski ES: Cytomegalovirus Biology and Replication. In The Human Herpesviruses Edited by: Roizman B and Whitley RJ. New York, Raven Press Ltd; 1993.
3. Nerheim PL, Meier JL, Vasef MA, Li WG, Hu L, Rice JB, Gavrila D, Richenbacher WE, Weintraub NL: Enhanced cytomegalovirus infection in atherosclerotic human blood vessels. Am J Pathol 2004, 164:589-600.
4. Melnick JL, Adam E, Debakey ME: Cytomegalovirus and atherosclerosis. Eur Heart J 1993, 14 Suppl K:30-38.
5. Britt W: Congenital cytomegalovirus infection. In Sexually transmitted diseases and adverse outcomes of pregnancy 1st edition. Edited by: Hitchcock PJ and Wasserheit JN. Washington D.C., ASM Press; 1999:269-281.
6. Song BH, Lee GC, Moon MS, Cho YH, Lee CH: Human cytomegalovirus binding to heparan sulfate proteoglycans on the cell surface and/or entry stimulates the expression of human leukocyte antigen class I. J Gen Virol 2001, 82:2405-2413.
7. Wang X, Huong SM, Chiu ML, Raab-Traub N, Huang ES: Epidermal growth factor receptor is a cellular receptor for human cytomegalovirus. Nature 2003, 424:456-461.
8. Huang ES, Kowalik TF: Molecular Aspects of Human Cytomegalovirus Diseases. Edited by: Becker Y, Darai G and Huang ES. Berlin, Springer; 1993.
9. Dunn HS, Haney DJ, Ghanekar SA, Stepick-Biek P, Lewis DB, Maecker HT: Dynamics of CD4 and CD8 T cell responses to cytomegalovirus in healthy human donors. J Infect Dis 2002, 186:15-22.
10. Falk CS, Mach M, Schendel DJ, Weiss EH, Hilgert I, Hahn G: NK cell activity during human cytomegalovirus infection is dominated by US2-11-mediated HLA class I down-regulation. J Immunol 2002, 169:3257-3266.
11. Wills MR, Carmichael AJ, Mynard K, Jin X, Weekes MP, Plachter B, Sissons JG: The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol 1996, 70:7569-7579.
12. Gillespie GM, Wills MR, Appay V, O'Callaghan C, Murphy M, Smith N, Sissons P, Rowland-Jones S, Bell JI, Moss PA: Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors. J Virol 2000, 74:8140-8150.
13. Gamadia LE, van Leeuwen EM, Remmerswaal EB, Yong SL, Surachno S, Wertheim-van Dillen PM, Ten Berge IJ, Van Lier RA: The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines. J Immunol 2004, 172:6107-6114.
14. Sester M, Sester U, Gartner BC, Girndt M, Meyerhans A, Kohler H: Dominance of virus-specific CD8 T cells in human primary cytomegalovirus infection. J Am Soc Nephrol 2002, 13:2577-2584.
15. Rook AH, Quinnan GV Jr, Frederick WJ, Manischewitz JF, Kirmani N, Dantzler T, Lee BB, Currier CB Jr: Importance of cytotoxic lymphocytes during cytomegalovirus infection in renal transplant recipients. Am J Med 1984, 76:385-392.
16. Starr SE, Smiley L, Wlodaver C, Friedman HM, Plotkin SA, Barker C: Natural killing of cytomegalovirus-infected targets in renal transplant recipients. Transplantation 1984, 37:161-164.
17. Torigoe S, Campbell DE, Starr SE: Cytokines released by human peripheral blood mononuclear cells inhibit the production of early and late cytomegalovirus proteins. Microbiol Immunol 1997, 41:403-413.
18. Weinberg A, Wohl DA, MaWhinney S, Barrett RJ, Brown DG, Glomb N, van der Horst C: Cytomegalovirus-specific IFN-gamma production is associated with protection against cytomegalovirus reactivation in HIV-infected patients on highly active antiretroviral therapy. Aids 2003, 17:2445-2450.
19. Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Golenbock DT, Finberg RW: Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 2003, 77:4588-4596.
20. Sainz B Jr, Halford WP: Alpha/Beta interferon and gamma interferon synergize to inhibit the replication of herpes simplex virus type 1. J Virol 2002, 76:11541-11550.
21. Guidotti LG, Chisari FV: Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001, 19:65-91.
22. Rodriguez JE, Loepfe TR, Swack NS: Beta interferon production in primed and unprimed cells infected with human cytomegalovirus. Arch Virol 1987, 94:177-189.
23. Thomson A: The cytokine handbook, 3rd ed. San Diego, CA, Academic Press; 1998.
24. Miller DM, Zhang Y, Rahill BM, Waldman WJ, Sedmak DD: Human cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction. J Immunol 1999, 162:6107-6113.
25. Pfeffer LM, Dinarello CA, Herberman RB, Williams BR, Borden EC, Bordens R, Walter MR, Nagabhushan TL, Trotta PP, Pestka S: Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res 1998, 58:2489-2499.
26. Goodbourn S, Didcock L, Randall RE: Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 2000, 81:2341-2364.
27. Katze MG, He Y, Gale M Jr: Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2002, 2:675-687.
28. Miller DM, Rahill BM, Boss JM, Lairmore MD, Durbin JE, Waldman JW, Sedmak DD: Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med 1998, 187:675-683.
29. Miller DM, Cebulla CM, Sedmak DD: Human cytomegalovirus inhibition of major histocompatibility complex transcription and interferon signal transduction. Curr Top Microbiol Immunol 2002, 269:153-170.
30. Boehme KW, Compton T: Innate sensing of viruses by toll-like receptors. J Virol 2004, 78:7867-7873.
31. Child SJ, Hakki M, De Niro KL, Geballe AP: Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1. J Virol 2004, 78:197-205.
32. Browne EP, Shenk T: Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells. Proc Natl Acad Sci U S A 2003, 100:11439-11444.
33. He B, Gross M, Roizman B: The gamma 134.5 protein of herpes simplex virus 1 has the structural and functional attributes of a protein phosphatase 1 regulatory subunit and is present in a high molecular weight complex with the enzyme in infected cells. J Biol Chem 1998, 273:20737-20743.
34. Garcia-Sastre A, Egorov A, Matassov D, Brandt S, Levy DE, Durbin JE, Palese P, Muster T: Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 1998, 252:324-330.
35. Young DF, Didcock L, Goodbourn S, Randall RE: Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. Virology 2000, 269:383-390.
36. Komatsu T, Takeuchi K, Yokoo J, Tanaka Y, Gotoh B: Sendai virus blocks alpha interferon signaling to signal transducers and activators of transcription. J Virol 2000, 74:2477-2480.
37. He Y, Katze MG: To interfere and to anti-interfere: the interplay between hepatitis C virus and interferon. Viral Immunol 2002, 15:95-119.
38. Basler CF, Wang X, Muhlberger E, Volchkov V, Paragas J, Klenk HD, Garcia-Sastre A, Palese P: The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A 2000, 97:12289-12294.
39. Sainz B Jr, Mossel EC, Peters CJ, Garry RF: Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Virology 2004, 329:11-17.
40. Larkin J, Jin L, Farmen M, Venable D, Huang Y, Tan SL, Glass JI: Synergistic antiviral activity of human interferon combinations in the hepatitis C virus replicon system. J Interferon Cytokine Res 2003, 23:247-257.
41. Asper M, Sternsdorf T, Hass M, Drosten C, Rhode A, Schmitz H, Gunther S: Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus. J Virol 2004, 78:3162-3169.
42. Loewe S: Die quantitativen Probleme der Pharmakologie. Ergebn Physiol 1928, 27:47-187.
43. Berenbaum MC: What is synergy? Pharmacol Rev 1989, 41:93-141.
44. Yurochko AD, Kowalik TF, Huong SM, Huang ES: Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J Virol 1995, 69:5391-5400.
45. Stinski MF, Thomsen DR, Rodriguez JE: Synthesis of human cytomegalovirus-specified RNA and protein in interferon-treated cells at early times after infection. J Gen Virol 1982, 60:261-270.
46. Cheeran MC, Hu S, Gekker G, Lokensgard JR: Decreased cytomegalovirus expression following proinflammatory cytokine treatment of primary human astrocytes. J Immunol 2000, 164:926-933.
47. Greaves RF, Mocarski ES: Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant. J Virol 1998, 72:366-379.
48. Yamamoto N, Shimokata K, Maeno K, Nishiyama Y: Effect of recombinant human interferon gamma against human cytomegalovirus. Arch Virol 1987, 94:323-329.
49. Gawn JM, Greaves RF: Absence of IE1 p72 protein function during low-multiplicity infection by human cytomegalovirus results in a broad block to viral delayed-early gene expression. J Virol 2002, 76:4441-4455.
50. Mocarski ES, Kemble GW, Lyle JM, Greaves RF: A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoregulation. Proc Natl Acad Sci U S A 1996, 93:11321-11326.
51. Der SD, Zhou A, Williams BR, Silverman RH: Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A 1998, 95:15623-15628.
52. Huang ES: Human cytomegalovirus. III. Virus-induced DNA polymerase. J Virol 1975, 16:298-310.
53. Isomura H, Stinski MF: The human cytomegalovirus major immediate-early enhancer determines the efficiency of immediate-early gene transcription and viral replication in permissive cells at low multiplicity of infection. J Virol 2003, 77:3602-3614.
54. Treco DA: Preparation and analysis of DNA, p.2.0.3-2.2.3. In Current protocols in molecular biology Edited by: Ausubel FM. New York, N.Y., John Wiley & Sons; 1990.
55. Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, Sinclair JH: Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 1991, 72 (Pt 9):2059-2064.
56. White EA, Clark CL, Sanchez V, Spector DH: Small internal deletions in the human cytomegalovirus IE2 gene result in nonviable recombinant viruses with differential defects in viral gene expression. J Virol 2004, 78:1817-1830.
57. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:e45..
58. Soderberg-Naucler C, Streblow DN, Fish KN, Allan-Yorke J, Smith PP, Nelson JA: Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent. J Virol 2001, 75:7543-7554.